Jobs / United States / Astrazeneca Pharmaceuticals Lp
Transforming Care Lead – Respiratory and Immunology (R&I)
Astrazeneca Pharmaceuticals Lp · 🇺🇸 Field PS
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles10 certified filings for “Scientist, Cancer Immunology, Oncology Research” (Biochemists and Biophysicists) in MD: $104k–$138k, median $130k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Position: Transforming Care Lead – Respiratory and Immunology (R&I) Location: Field-based, UK Competitive Salary & Excellent Company Benefits Applications Closing Date: 2 November 2026 Introduction to the Role At AstraZeneca UK, Medical & Scientific Affairs plays a pivotal role in improving patient outcomes by working collaboratively with NHS partners to support meaningful and sustainable changes in healthcare delivery. As Transforming Care Lead – Respiratory and Immunology (R&I), you will lead the development and implementation of the R&I transforming care strategy. Working in partnership with therapy-area Medical and Brand teams, you will help ensure NHS systems are ready to identify, diagnose and optimally manage relevant patients ahead of, and throughout, the launch period. Using population health and pathways expertise, you will accelerate the implementation of guideline-directed care at scale across respiratory and immunology pathways. You will identify pathway, diagnostic and capacity gaps, prioritise opportunities using population health data and drive improvements across clinical systems, medicines optimisation, care pathways and collaborative working models. The role operates on a non-promotional medical basis. You will work closely with Brand and Commercial colleagues while retaining independent medical judgement and ensuring that supported system changes are clinically appropriate, evidence-based and aligned with the needs of patients and NHS systems. Key Accountabilities Transforming Care Strategy and System Readiness You will partner with R&I Medical and Brand teams to define the therapy-area transforming care strategy and lead the development and delivery of system readiness plans for R&I launches. This will involve assessing pathway, diagnostic and capacity gaps, sequencing the changes required and reporting readiness status through launch governance. You will direct the use of linked datasets, secure data environments and NHS data partnerships to identify the populations and health systems where intervention is most likely to deliver meaningful impact. Your approach will be evidence-led, prioritising opportunities according to population need and potential system impact rather than responding solely to inbound requests. You will ensure that pathways, clinical systems, medicines optimisation and collaborative working initiatives are aligned to the R&I transforming care strategy. You will build a strong network of external expert partners to provide insight into the changing NHS landscape and identify future opportunities for AstraZeneca UK to collaborate on transforming care projects. A key part of the role will be gathering and interpreting population health analytics at national, system and local levels. You will integrate new providers into relevant local or national projects and ensure that every transforming care initiative has a clearly defined evaluation approach, including agreed baselines and outcome measures at the design stage. You will share evaluation findings internally and, where appropriate, support publication or external presentation of outcomes. You will also be accountable for the R&I transforming care budget, prioritising investment across initiatives to maximise system impact. Implementation of Population Health and Pathways Initiatives You will lead the implementation of population health and pathways initiatives across respiratory and immunology clinical systems, medicines optimisation, patient pathways and collaborative working models. You will ensure that initiatives are joined up, coordinated and strategically aligned with the transforming care strategy. This will require close collaboration with field medical team managers and alignment across internal stakeholders,